Sanchem Life Science

Sanchem Life Science is committed to delivering high-quality pharmaceutical and healthcare products with a focus on innovation, quality, and customer satisfaction. We strive to provide reliable solutions that meet global healthcare standards.

Intrinsicly evisculate emerging cutting edge scenarios redefine future-proof e-markets demand line

Gallery Posts

delivery Trusted pharmaceutical solutions for every stage of life

customer-service Need Help? +91 9811494850

Zitgesic-P (Tablets)

Zitgesic-P (Tablets)

Zitgesic-P is a pain relief tablet formulation from Sanchem, likely combining an analgesic agent with paracetamol (indicated by


Description

Understanding Zitgesic-P

Pain and fever are among the most common symptoms experienced across a wide range of everyday conditions, from headaches and body aches to fever associated with infections. Zitgesic-P, developed by Sanchem, is formulated to provide effective, combined relief for these common symptoms through a well-established analgesic and antipyretic approach.

A Combination for Everyday Relief

Combining an analgesic agent with paracetamol allows Zitgesic-P to address pain through complementary mechanisms while providing reliable fever reduction. This type of combination is widely used because paracetamol offers a favorable safety profile for fever and mild-to-moderate pain when used at appropriate doses, while the additional analgesic component may enhance overall pain relief.

(Please confirm the exact active ingredients and their respective strengths in Zitgesic-P.)

Common Areas of Use

Zitgesic-P may be used for symptomatic relief of:

  • Headache and migraine-related pain
  • Body ache and muscular pain
  • Fever associated with cold, flu, or infections
  • Dental pain and minor injury-related discomfort

(Please confirm the exact approved indications based on your product's composition and regulatory approval.)

How It Works

[This section should explain the mechanism of action of the active ingredients in Zitgesic-P — for example, how paracetamol works centrally to reduce fever and pain perception, and the mechanism of the additional analgesic component. Please supply accurate pharmacological detail from your product documentation.]

Dosage and Administration

Dosage of Zitgesic-P should be determined based on the patient's age, weight, and severity of symptoms, following label instructions or physician guidance. Patients should not exceed the maximum recommended daily dose or use the product for more than a few days without consulting a doctor, particularly to avoid risks associated with excessive paracetamol intake.

Safety Information

Patients should inform their doctor of:

  • Any known allergies to the active ingredients or excipients
  • Pre-existing liver or kidney conditions
  • Regular or heavy alcohol use, which increases risk of liver toxicity with paracetamol
  • Other medications currently being taken, particularly other paracetamol-containing products, to avoid overdose

Zitgesic-P should be stored as per label instructions, in a cool, dry place away from direct sunlight, and kept out of reach of children.

Quality You Can Trust

Every batch of Zitgesic-P is manufactured in a GMP-compliant facility under strict quality assurance protocols, with rigorous testing conducted at each stage to ensure consistent potency, purity, and safety.

Why Choose Sanchem's Zitgesic-P

Zitgesic-P reflects Sanchem's commitment to providing effective, dependable solutions for everyday pain and fever management, offering patients a trusted option for common symptomatic relief.

A Note for Healthcare Professionals

Sanchem welcomes healthcare providers to reach out for detailed prescribing information and dosing guidelines to support informed treatment recommendations for their patients.

(This description uses general, non-specific pharmacological framing. Please insert the confirmed active ingredients, strengths, mechanism of action, approved indications, contraindications, and dosage information from your official prescribing information before publishing.)